Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 83

1.

Bromelain's activity and potential as an anti-cancer agent: Current evidence and perspectives.

Chobotova K, Vernallis AB, Majid FA.

Cancer Lett. 2010 Apr 28;290(2):148-56. doi: 10.1016/j.canlet.2009.08.001. Epub 2009 Aug 22. Review.

PMID:
19700238
2.

Bromelain, the enzyme complex of pineapple (Ananas comosus) and its clinical application. An update.

Taussig SJ, Batkin S.

J Ethnopharmacol. 1988 Feb-Mar;22(2):191-203. Review.

PMID:
3287010
3.

Bromelain inhibits COX-2 expression by blocking the activation of MAPK regulated NF-kappa B against skin tumor-initiation triggering mitochondrial death pathway.

Bhui K, Prasad S, George J, Shukla Y.

Cancer Lett. 2009 Sep 18;282(2):167-76. doi: 10.1016/j.canlet.2009.03.003. Epub 2009 Mar 31.

PMID:
19339108
4.

Bromelain activates murine macrophages and natural killer cells in vitro.

Engwerda CR, Andrew D, Murphy M, Mynott TL.

Cell Immunol. 2001 May 25;210(1):5-10.

PMID:
11485347
5.

Bromelain inhibits lipopolysaccharide-induced cytokine production in human THP-1 monocytes via the removal of CD14.

Huang JR, Wu CC, Hou RC, Jeng KC.

Immunol Invest. 2008;37(4):263-77. doi: 10.1080/08820130802083622.

PMID:
18569070
6.

New drugs in cancer therapy, National Tumor Institute, Naples, 17-18 June 2004.

Caponigro F, Basile M, de Rosa V, Normanno N.

Anticancer Drugs. 2005 Feb;16(2):211-21.

PMID:
15655420
7.

New paradigms in anticancer therapy: targeting multiple signaling pathways with kinase inhibitors.

Faivre S, Djelloul S, Raymond E.

Semin Oncol. 2006 Aug;33(4):407-20. Review.

PMID:
16890796
8.

Bromelain reversibly inhibits invasive properties of glioma cells.

Tysnes BB, Maurer HR, Porwol T, Probst B, Bjerkvig R, Hoover F.

Neoplasia. 2001 Nov-Dec;3(6):469-79.

9.
10.
11.

Bromelain, from pineapple stems, proteolytically blocks activation of extracellular regulated kinase-2 in T cells.

Mynott TL, Ladhams A, Scarmato P, Engwerda CR.

J Immunol. 1999 Sep 1;163(5):2568-75.

12.

Regulation of p53, nuclear factor kappaB and cyclooxygenase-2 expression by bromelain through targeting mitogen-activated protein kinase pathway in mouse skin.

Kalra N, Bhui K, Roy P, Srivastava S, George J, Prasad S, Shukla Y.

Toxicol Appl Pharmacol. 2008 Jan 1;226(1):30-7. Epub 2007 Aug 23.

PMID:
17889918
13.
14.

Therapeutic uses of pineapple-extracted bromelain in surgical care - A review.

Muhammad ZA, Ahmad T.

J Pak Med Assoc. 2017 Jan;67(1):121-125.

15.

Bromelain modulates T cell and B cell immune responses in vitro and in vivo.

Engwerda CR, Andrew D, Ladhams A, Mynott TL.

Cell Immunol. 2001 May 25;210(1):66-75.

PMID:
11485354
16.
18.

Anticancer property of bromelain with therapeutic potential in malignant peritoneal mesothelioma.

Pillai K, Akhter J, Chua TC, Morris DL.

Cancer Invest. 2013 May;31(4):241-50. doi: 10.3109/07357907.2013.784777. Epub 2013 Apr 9. Review.

PMID:
23570457
19.

Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments.

Melisi D, Troiani T, Damiano V, Tortora G, Ciardiello F.

Endocr Relat Cancer. 2004 Mar;11(1):51-68. Review.

20.

In vivo antitumoral activity of stem pineapple (Ananas comosus) bromelain.

Báez R, Lopes MT, Salas CE, Hernández M.

Planta Med. 2007 Oct;73(13):1377-83. Epub 2007 Sep 24.

PMID:
17893836

Supplemental Content

Support Center